Shengsi Biopharmaceutical
晟斯生物
Shengsi Biopharmaceutical
Biotech/Healthcare
Shengsi Biotech comprises three entities: Haimen Shengsi Biopharmaceutical Co., Ltd., Beijing Jike Shengsi Pharmaceutical Technology Co., Ltd., and Zhengzhou Shengsi Biotechnology Co., Ltd. The company develops novel biologic drugs, with capabilities spanning early-stage R&D, pilot-scale expansion…
Latest round: Series C Extension (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.